$ 26.11
Key Takeaways
Risk factor
Meaningful price volatility
Profitability factor
Strong margins and returns
About
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of STVN is 28 and suggests 7% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
